Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Histopathology|September 18, 2020
Prevalence and potential biological role of TERT amplifications in ALK translocated adenocarcinoma of the lungChristina Alidousty, Nicolai Duerbaum, Svenja Wagener-Ryczek, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Acquired KRAS mutation and loss of low-level MET amplification after durable response to crizotinib in a patient with lung adenocarcinomaRichard Riedel, Sebastian Michels, Carina Heydt, et al.
The Journal of Molecular Diagnostics : JMD|June 5, 2026
Pitfalls in detecting MET exon 14 skipping variants by DNA- and RNA- based next generation sequencing technologies in a large real-world cohort and results of the first multinational EQA schemesCarina Heydt, Michaela Angelika Ihle, Katharina Ilm, et al.
NPJ Precision Oncology|June 7, 2018
<i>ALK</i><sup>G1269A</sup> mutation as a potential mechanism of acquired resistance to crizotinib in an <i>ALK</i>-rearranged inflammatory myofibroblastic tumorSebastian Y F Michels, Andreas H Scheel, Thomas Wündisch, et al.
The Journal of Pathology|June 10, 2018
Genetic instability and recurrent MYC amplification in ALK-translocated NSCLC: a central role of TP53 mutationsChristina Alidousty, Till Baar, Luciano G Martelotto, et al.
Scientific Reports|June 6, 2024
Multinational proficiency tests for EGFR exon 20 insertions reveal that the assay design mattersMichaela A Ihle, Carina Heydt, Anne Maria Schultheis, et al.
JTO Clinical and Research Reports|March 12, 2026
MET-Driven Resistance to Sotorasib in KRAS G12C-Mutant NSCLC and Response to Combined KRAS and MET InhibitionRichard Riedel, Lea Ruge, Malte Verheyen, et al.
BMC Medical Genomics|February 28, 2021
Detection of gene fusions using targeted next-generation sequencing: a comparative evaluationCarina Heydt, Christina B Wölwer, Oscar Velazquez Camacho, et al.
The Journal of Molecular Diagnostics : JMD|May 8, 2021
Validation of a Targeted Next-Generation Sequencing Panel for Tumor Mutation Burden Analysis: Results from the Onconetwork Immuno-Oncology ConsortiumFrancesca Fenizia, Ilaria Alborelli, Jose Luis Costa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2018
Clinical and Pathological Characteristics of <i>KEAP1</i>- and <i>NFE2L2</i>-Mutated Non-Small Cell Lung Carcinoma (NSCLC)Rieke Frank, Matthias Scheffler, Sabine Merkelbach-Bruse, et al.
Pageof 6